CM
Methodology breakdown computing — it will appear here on its own.
Clearmind Medicine Inc (CMND) is currently considered not halal (non-compliant), per our secondary compliance provider (last assessed 2026-06-16). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
Computing the full ratio and business-activity breakdown for CMND — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 26.70 | BUY |
| Stochastic %K (14) | 5.25 | BUY |
| CCI (20) | -193.62 | BUY |
| Williams %R (14) | -94.75 | BUY |
| MACD (12,26,9) | -0.08 | SELL |
| ROC (10) | -42.91 | SELL |
| Momentum (10) | -0.74 | SELL |
| EMA (10) | 1.38 | SELL |
| SMA (10) | 1.51 | SELL |
| EMA (20) | 1.55 | SELL |
| SMA (20) | 1.66 | SELL |
| EMA (30) | 1.67 | SELL |
| SMA (30) | 1.66 | SELL |
| EMA (50) | 2.18 | SELL |
| SMA (50) | 1.76 | SELL |
| EMA (100) | 12.22 | SELL |
| SMA (100) | 3.12 | SELL |
| EMA (200) | 60.41 | SELL |
| SMA (200) | 12.37 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Biotechnology
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 43 |
| ⏰ 4H | RANGING | 30 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | RANGING | 130 |
| ⏲ 5-Min | RANGING | 234 |
Peer movement computing — it will appear here on its own.
BEARISH 0 buys · 2 sells
Recent: HRT FINANCIAL LP sold 103492 sh @ $3.32 (2026-06-15); HRT FINANCIAL LP sold 81353 sh @ $3.31 (2026-06-16)
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.